Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
FDA
Biotech
Takeda leader says AI gave early-stage asset a 'phoenix' rebirth
Takeda's R&D head shares about the drugmaker's AI implementation across all discovery efforts and warns against long-term risks for U.S. innovation.
Gabrielle Masson
Jan 13, 2026 6:16am
BrainSpace gets FDA clearance for brain fluid management system
Jan 6, 2026 4:05pm
FDA shares CRL for Sanofi MS drug mere weeks after rebuff
Jan 6, 2026 4:30am
Biobeat drums up $50M to support cuffless blood pressure monitor
Jan 5, 2026 8:35am
Fierce Biotech's 10 most-read stories of 2025
Dec 29, 2025 7:00am
Edwards nets FDA approval for Sapien M3 mitral valve replacement
Dec 23, 2025 11:00am
